C3.ai, Inc. AI
C3.ai, Inc. (AI) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2026 revenue was $250.3M at a -187.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.73 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.737 |
| Retained earnings / assets | -2.265 |
| EBIT / assets | -0.611 |
| Equity / liabilities | 4.023 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AI | C3.ai, Inc. | 1/9 | -2.43 | — | -35.7% |
| CRNC | Cerence Inc. | 5/9 | -3.62 | — | -24% |
| LPSN | LIVEPERSON INC | 3/9 | -8.64 | — | -22% |
| DH | Definitive Healthcare Corp. | 5/9 | -3.49 | — | -4.2% |
| VTEX | VTEX | 7/9 | 5.07 | 30.9 | +6.1% |
| WEAV | Weave Communications, Inc. | 5/9 | -4.66 | — | +17% |
| GCL | GCL Global Holdings Ltd | 5/9 | 2.01 | — | +68.2% |
About C3.ai, Inc.
C3.ai, Inc. operates as an enterprise artificial intelligence application software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It offers C3 agentic AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Studio, an integrated development environment in the C3 Agentic AI Platform that enables engineers, data scientists, and business analysts to design, build, test, and deploy AI applications; C3 AI Applications, a portfolio of industry-specific enterprise AI applications that enables the digital transformation of organizations globally; and C3 Generative AI, a library of agentic AI applications to retrieve data, analyze information, surface insights, and orchestrate workflows. The company also provides C3 Code, a solution that enables users to build, configure, and deploy a complete and production-grade Enterprise AI applications automatically, including data pipelines, AI models, business logic, security controls, and user interfaces. It has strategic partnerships with Microsoft, AWS, Google Cloud, McKinsey & Company, and Baker Hughes. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.
FAQ
Is AI financially healthy?
C3.ai, Inc.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AI pay a dividend?
No, C3.ai, Inc. does not currently pay a dividend.
How profitable is AI?
In FY2026, C3.ai, Inc. had a net margin of -187.9% and a return on equity of -71.9%.
What is the analyst price target for AI?
The average Wall-Street price target for C3.ai, Inc. is $8.82, about 12.5% below the recent price, from 11 analysts.
Is AI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on C3.ai, Inc.: a Piotroski F-score of 1/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-04-30. Facts plus Stocktoria's own computed scores — not investment advice.